NCT07144007 Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study
| NCT ID | NCT07144007 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yuzuncu Yil University |
| Condition | Emergence Agitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-04-15 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine
Eligibility Criteria
Inclusion Criteria: * Patients scheduled for rhinoplasty * Between 18-65 years * ASA I-II group Exclusion Criteria: * Those who are outside the age range of 18-65 * Those who are ASA III and above * Those with renal,hepatic, cardiac and respiratory diseases * Those with a known allergy to the medication to be used * Those who underwent urinary catheterization
Contact & Investigator
Şükran Sevimli, Assoc. Prof.
STUDY DIRECTOR
Yuzuncu Yil University
Frequently Asked Questions
Who can join the NCT07144007 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Emergence Agitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07144007 currently recruiting?
Yes, NCT07144007 is actively recruiting participants. Contact the research team at emin6559@hotmail.com for enrollment information.
Where is the NCT07144007 trial being conducted?
This trial is being conducted at Van, Turkey (Türkiye).
Who is sponsoring the NCT07144007 clinical trial?
NCT07144007 is sponsored by Yuzuncu Yil University. The principal investigator is Şükran Sevimli, Assoc. Prof. at Yuzuncu Yil University. The trial plans to enroll 80 participants.